Pages

Monday, July 11, 2011

Aureos invests $10 mn in Indian healthcare group BSR Super Speciality Hospitals

Aureos Capital, private equity fund management with a focus on emerging markets, has invested $10 million in a leading Indian healthcare group BSR Super Speciality Hospitals, said a top company official.

Sev Vettivetpillai, Chief Executive Officer of Aureos Capital told media last night that the group has completed USD 10 million investment in Central India-based hospital chain. "BSR's strategic alignment with Aureos will pave the way for continued expansion in its network of hospitals and diagnostic centres in wider geographies," he said.

Vettivetpillai added the hospital aims to start imaging diagnostic centres and several new hospitals in the region, including a 150-bed multi-speciality hospital in Nagpur and a hospital in Rajnandgaon.

"BSR currently owns and operates six diagnostic centres and two major hospitals across five cities in Central India. The hospitals include a 175-bed tertiary hospital (BSR Super Speciality Hospital, Bhilai) and the first specialist cancer hospital ( BSR Cancer Hospital )) in the state of Chattisgarh", he said.

BSR Super Speciality Hospital is the first tertiary care hospital in the region, providing thousands of patients to date with previously unattainable levels of care, he said.

The hospital chain also owns Bhilai Scan and Research Limited (BSRL), which operates imaging diagnostics centres fully equipped with radiology and pathology services, across Central India, he said. Aureos' India office is located in Mumbai.

Aureos Capital is a private equity fund management company specialising in providing expansion and buy-out capital to small and medium sized businesses across Asia, Africa and Latin America.

Since its establishment in 2001, Aureos has increased its funds under management to over USD 1.3 billion US dollars and extended its geographical footprint to over 50 emerging markets covering, Asia, Africa and Latin America by establishing 16 regional private equity funds, Vettivetpillai said.

"Investors in Aureos funds include institutional investors, bilateral and multilateral development finance institutions, pension funds, sovereign wealth funds, fund of funds, family offices and foundations and high net worth individuals," he added.